SCHEMBL23611417

SCHEMBL23611417

CC(C)Oc1ccc(-c2ncc(CNc3cc(-c4cnc[nH]4)nc(C(F)(F)F)c3)cn2)cc1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.37
▸ TP53 P04637 3/20 0.37
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ PTGS2 P35354 3/20 0.35
▸ RET P07949 1/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ FABP4 P15090 1/20 0.32
▸ FPR2 P25090 1/20 0.32
▸ SCN9A Q15858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30060478 1.00 MAPT (0.37) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL30060488 0.85 MAPT (0.38) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL23611516 0.85 MAPT (0.38) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL21611930 0.82 CYP2C9 (0.42) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL21614656 0.79 CYP2C19 (0.52) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL23611396 0.77 KDM4E (0.42) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL23611365 0.77 SMN1; SMN2 (0.40) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL23611330 0.75 MAPT (0.43) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL30061969 0.75 MAPT (0.43) MAPTTP53CYP1A2CYP2C9CYP2C19
SCHEMBL23611312 0.73 CYP2C9 (0.39) MAPTTP53CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085057-A1 NOVEL PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
WO-2021136805-A1 NOVEL PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-07-08 — — WO disclosed
Send feedback